Dr. Chen is an Assistant Research Fellow at the Agricultural Biotechnology Research Center, Academia Sinica. After starting her career as a pharmacist, she earned her Ph.D. from the Institute of Pharmacology at National Yang Ming Chiao Tung University. Before joining Academia Sinica, she was a research scientist at the Immunotherapy Research Center at Houston Methodist Research Institute. Drawing on her interdisciplinary expertise in pharmacy, pharmacology, and immunology, Dr. Chen’s research aims to connect basic scientific discovery with translational applications. Her primary focus is on developing new immunotherapies and natural product-based therapeutics. Her team investigates the biology of pathological myeloid cells—specifically how they interact with other cells in the tumor microenvironment and their role in subsequent immune responses. A significant area of her work involves studying these myeloid cells in the context of persistent inflammation, which is common in conditions like cancer and aging. Furthermore, Dr. Chen has identified several medicinal plant-derived products as potential myeloid-targeted phyto-medicines, offering promising directions for new drug development and immunomodulatory and nutritional therapies.

Jason Liang-Ju Lin, PhD, is a researcher at the Institute of Molecular Biology, Academia Sinica, Taiwan. His research focuses on structural and molecular mechanisms of protein kinases, including PKC-related protein kinase N1 (PKN1), and mitochondrial endonucleases. He has published multiple first-author papers and holds patents in these areas, with interests spanning kinase regulation, structural biology, and translational drug discovery.